| Biosimilars advancements: moving on to the future LR Tsuruta, M Lopes dos Santos, AM Moro Biotechnology progress 31 (5), 1139-1149, 2015 | 94 | 2015 |
| Advances and challenges in therapeutic monoclonal antibodies drug development ML Santos, W Quintilio, TM Manieri, LR Tsuruta, AM Moro Brazilian Journal of Pharmaceutical Sciences 54 (SPE), 2018 | 66 | 2018 |
| Interactions between cationic liposomes and an antigenic protein: the physical chemistry of the immunoadjuvant action. LR Tsuruta, W Quintilio, MH Costa, AM Carmona-Ribeiro Journal of lipid research 38 (10), 2003-2011, 1997 | 54 | 1997 |
| Effect of particle size on colloid stability of bilayer-covered polystyrene microspheres LR Tsuruta, MM Lessa, AM Carmona-Ribeiro Journal of colloid and interface science 175 (2), 470-475, 1995 | 54 | 1995 |
| Counterion effects on colloid stability of cationic vesicles and bilayer-covered polystyrene microspheres LR Tsuruta, AM Carmona-Ribeiro The Journal of Physical Chemistry 100 (17), 7130-7134, 1996 | 29 | 1996 |
| Interactions between dioctadecyldimethylammonium chloride or bromide bilayers in water LR Tsuruta, MM Lessa, AM Carmona-Ribeiro Langmuir 11 (8), 2938-2943, 1995 | 28 | 1995 |
| Rebmab200, a humanized monoclonal antibody targeting the sodium phosphate transporter NaPi2b displays strong immune mediated cytotoxicity against cancer: a novel reagent for … ML Dos Santos, FP Yeda, LR Tsuruta, BB Horta, AA Pimenta Jr, ... PloS one 8 (7), e70332, 2013 | 24 | 2013 |
| Anti-digoxin Fab variants generated by phage display VM Murata, MCB Schmidt, J Kalil, LR Tsuruta, AM Moro Molecular biotechnology 54 (2), 269-277, 2013 | 19 | 2013 |
| Characterization of 11-dehydro-thromboxane B2 recombinant antibody obtained by phage display technology LR Tsuruta, Y Tomioka, T Hishinuma, Y Kato, K Itoh, T Suzuki, H Oguri, ... Prostaglandins, leukotrienes and essential fatty acids 68 (4), 273-284, 2003 | 16 | 2003 |
| Display Technologies for the Selection of Monoclonal Antibodies for Clinical Use LR Tsuruta, AM Moro Antibody Engineering, 2017 | 14* | 2017 |
| Design, Production, and Characterization of Recombinant Neocarzinostatin Apoprotein in Escherichia coli S Nozaki, Y Tomioka, T Hishinuma, M Inoue, Y Nagum, LR Tsuruta, ... The Journal of Biochemistry 131 (5), 729-738, 2002 | 13 | 2002 |
| Genetic analyses of Per. C6 cell clones producing a therapeutic monoclonal antibody regarding productivity and long-term stability LR Tsuruta, ML Dos Santos, FP Yeda, OK Okamoto, AM Moro Applied microbiology and biotechnology 100 (23), 10031-10041, 2016 | 8 | 2016 |
| A new CHO (Chinese hamster ovary)-derived cell line expressing anti-TNFα monoclonal antibody with biosimilar potential MD Luchese, ML dos Santos, A Garbuio, RC Targino, CP Mansueli, ... Immunologic research 66 (3), 392-405, 2018 | 7 | 2018 |
| A natural carrier effect and the generation of specific antibodies to biologically active peptides LR Tsuruta, MAF Hayashi, K Konno, DV Tambourgi, MT Assakura, ... Analytical biochemistry 353 (2), 174-180, 2006 | 3 | 2006 |
| Strategies for clone detection, selection and isolation in Per. C6 cells-case for Rebmab100 FP Yeda, ML dos Santos, LR Tsuruta, BB Horta, AL Inocencio, ... BMC proceedings 7 (6), P38, 2013 | 2 | 2013 |
| Strategies to improve productivity of CHO-S cells expressing an anti-TNFα monoclonal antibody with biosimilar potential AM Moro, M Luchese, L Tsuruta, W Quintilio, ML Santos | | 2018 |
| Expression of bradykinin-potentiating peptides (BPPs) precursor protein and generation of specific antibodies D Stuart, LR Tsuruta, K Konno, MT Assakura, A Camargo, MAF Hayashi, ... | | 2005 |
| Production and characterization of recombinant antibodies against prostaglandin obtained by phage display technology (ファージディスプレイ法を用いた抗プロスタノイドリコンビナント抗体の作製と特質) LR Tsuruta | | 2003 |
